March 02, 2021 Corporate News

• PEKO Announces Strategic Partnership with FORGE
•  
• ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III Investors to Secure Counsel Before Important Deadline - CLOV, CLOVW, IPOC
•  
• HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Infinity Q Diversified Alpha Fund (IQDAX; IQDNX) Investors with Losses to Contact Its Attorneys, Fund Halts Redemptions and Suspends Chief Investment Officer
•  
• World's Fastest COVID-19 Virus Detection Insta-Test: Results in Under 15 Seconds
•  
• New Alzheimer's Association Report Examines Racial and Ethnic Attitudes on Alzheimer's and Dementia Care
•  
• Volvo Cars to be fully electric by 2030
•  
• Twitter cracks down on COVID vaccine misinformation
•  
• Saudi envoy disputes crown prince role in Khashoggi killing
•  
• Infuriated by Dems dropping minimum wage hike, progressives say 'time for wealth tax'
•  
• Biden voices support for unions amid landmark Amazon vote
•  
• Authorities rescue 5 from truck trapped in flooded creek in Tennessee
•  
• Second Ori’Zaba’s Franchise Location in Houston
•  
• MONARCH ergo teams up with Naruvi Hospitals, to create the most unique work space solutions in the industry
•  
• PlusDental: German Start-Up with Multi-million investment in Spain's aligner market
•  
• Learning and Assessment Specialist’s Managing Director Chosen to Speak for Scotland
•  
• SGS’s ANSI BIFMA Furniture Testing Service Helps Furniture Manufacturers Get Listings in the New ‘BIFMA Compliant’ Register
•  
• BankingON Named Mobile/Digital Finalist in CreditUnions.com 2021 Innovations Series
•  
• Interpreters Unlimited Helps Linguists Get Vaccinated
•  
• Pay Our Interns: It's Time to End Unpaid Work
•  
• Akastor ASA: Baker Hughes and Akastor ASA announce joint venture company to deliver global offshore drilling solutions
•  
• Shochiku Offers Future Kabuki Experience with AR Technology
•  
• European Companies On 2.7 °C Warming Path, According To CDP And Oliver Wyman
•  
• CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody
•